{"id":"https://openalex.org/W2013018548","doi":"https://doi.org/10.1111/j.1349-7006.2003.tb01492.x","title":"Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice","display_name":"Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice","publication_year":2003,"publication_date":"2003-07-01","ids":{"openalex":"https://openalex.org/W2013018548","doi":"https://doi.org/10.1111/j.1349-7006.2003.tb01492.x","mag":"2013018548","pmid":"https://pubmed.ncbi.nlm.nih.gov/12841871","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11160211"},"language":"en","primary_location":{"id":"doi:10.1111/j.1349-7006.2003.tb01492.x","doi":"https://doi.org/10.1111/j.1349-7006.2003.tb01492.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1349-7006.2003.tb01492.x","pdf_url":null,"source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11160211/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082163934","display_name":"Tomohiro Kitamura","orcid":"https://orcid.org/0000-0003-3900-1898","observed_orcids":["https://orcid.org/0000-0003-3900-1898"]},"institutions":[{"id":"https://openalex.org/I4405287541","display_name":"National Cancer Center Research Institute","ror":"https://ror.org/05fd4mq57","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405287541"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomohiro Kitamura","raw_affiliation_strings":["Cancer Prevention Basic Research Project, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan","Cancer Prevention Basic Research Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104\u20130045"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Prevention Basic Research Project, National Cancer Center Research Institute, Chuo-ku, Tokyo 104-0045, Japan","institution_ids":["https://openalex.org/I4405287541"]},{"raw_affiliation_string":"Cancer Prevention Basic Research Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104\u20130045","institution_ids":["https://openalex.org/I4405287541"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110076750","display_name":"Masaki Itoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I115498069","display_name":"Jikei University School of Medicine","ror":"https://ror.org/039ygjf22","country_code":"JP","type":"education","lineage":["https://openalex.org/I115498069"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaki Itoh","raw_affiliation_strings":["Oncology Department, Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105\u20138461"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Department, Jikei University School of Medicine, 3-25-8 Nishi-Shinbashi, Minato-ku, Tokyo 105\u20138461","institution_ids":["https://openalex.org/I115498069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111517612","display_name":"Tetsuo Noda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086780","display_name":"Japan Science and Technology Agency","ror":"https://ror.org/00097mb19","country_code":"JP","type":"government","lineage":["https://openalex.org/I1319490839","https://openalex.org/I4210086780"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuo Noda","raw_affiliation_strings":["Cell Biology Department, Cancer Institute, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo 170\u20138455","The Core Research for Evolutional Science and Technology Program, Japan Science and Technology Corporation, 4-1-8 Motomachi, Kawaguchi 332\u20130012"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cell Biology Department, Cancer Institute, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo 170\u20138455","institution_ids":[]},{"raw_affiliation_string":"The Core Research for Evolutional Science and Technology Program, Japan Science and Technology Corporation, 4-1-8 Motomachi, Kawaguchi 332\u20130012","institution_ids":["https://openalex.org/I4210086780"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043225508","display_name":"Kousuke Tani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kousuke Tani","raw_affiliation_strings":["Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108205271","display_name":"Michiyoshi Kobayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michiyoshi Kobayashi","raw_affiliation_strings":["Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077691716","display_name":"Takayuki Maruyama","orcid":"https://orcid.org/0000-0003-2205-8310","observed_orcids":["https://orcid.org/0000-0003-2205-8310"]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takayuki Maruyama","raw_affiliation_strings":["Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052586730","display_name":"Kaoru Kobayashi","orcid":"https://orcid.org/0000-0002-8105-6377","observed_orcids":["https://orcid.org/0000-0002-8105-6377"]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kaoru Kobayashi","raw_affiliation_strings":["Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002066699","display_name":"Shuichi Ohuchida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shuichi Ohuchida","raw_affiliation_strings":["Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Minase Research Institute, Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamoto-cho, Mishima-gun, Osaka 618\u20138585","institution_ids":["https://openalex.org/I4210112155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105501776","display_name":"Takashi S\u00fcgimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405287541","display_name":"National Cancer Center Research Institute","ror":"https://ror.org/05fd4mq57","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405287541"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Sugimura","raw_affiliation_strings":["Cancer Prevention Basic Research Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104\u20130045"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Prevention Basic Research Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104\u20130045","institution_ids":["https://openalex.org/I4405287541"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101399583","display_name":"Keiji Wakabayashi","orcid":"https://orcid.org/0000-0003-4746-4702","observed_orcids":["https://orcid.org/0000-0003-4746-4702"]},"institutions":[{"id":"https://openalex.org/I4405287541","display_name":"National Cancer Center Research Institute","ror":"https://ror.org/05fd4mq57","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210087348","https://openalex.org/I4405287541"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Keiji Wakabayashi","raw_affiliation_strings":["Cancer Prevention Basic Research Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104\u20130045"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Prevention Basic Research Project, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104\u20130045","institution_ids":["https://openalex.org/I4405287541"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5101399583"],"corresponding_institution_ids":["https://openalex.org/I4405287541"],"apc_list":{"value":2600,"currency":"USD","value_usd":2600},"apc_paid":null,"fwci":1.5434,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.8033783,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"94","issue":"7","first_page":"618","last_page":"621"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prostaglandin-e2","display_name":"prostaglandin E2","score":0.8769999742507935},{"id":"https://openalex.org/keywords/ep1-receptor-antagonist","display_name":"EP1 receptor antagonist","score":0.9169999957084656},{"id":"https://openalex.org/keywords/ep4-receptor-antagonist","display_name":"EP4 receptor antagonist","score":1.0},{"id":"https://openalex.org/keywords/intestinal-tumorigenesis","display_name":"intestinal tumorigenesis","score":0.7509999871253967},{"id":"https://openalex.org/keywords/adenomatous-polyposis-coli","display_name":"adenomatous polyposis coli","score":0.8920000195503235},{"id":"https://openalex.org/keywords/intestinal-polyps","display_name":"intestinal polyps","score":0.6850000023841858},{"id":"https://openalex.org/keywords/chemoprevention","display_name":"chemoprevention","score":0.8119999766349792},{"id":"https://openalex.org/keywords/colon-carcinogenesis","display_name":"colon carcinogenesis","score":0.8259999752044678},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6340000033378601},{"id":"https://openalex.org/keywords/additive-effects","display_name":"additive effects","score":0.5350000262260437}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6677858829498291},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.6285396814346313},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5802400708198547},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5780099630355835},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.5687711238861084},{"id":"https://openalex.org/C2910035481","wikidata":"https://www.wikidata.org/wiki/Q1209892","display_name":"Intestinal polyp","level":2,"score":0.5614545345306396},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5579367876052856},{"id":"https://openalex.org/C2780814781","wikidata":"https://www.wikidata.org/wiki/Q1369011","display_name":"Familial adenomatous polyposis","level":4,"score":0.5151857137680054},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4715065062046051},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4602801203727722},{"id":"https://openalex.org/C2777882243","wikidata":"https://www.wikidata.org/wiki/Q11090","display_name":"Small intestine","level":2,"score":0.45340695977211},{"id":"https://openalex.org/C2778237340","wikidata":"https://www.wikidata.org/wiki/Q14883378","display_name":"Adenomatous polyposis coli","level":4,"score":0.44831281900405884},{"id":"https://openalex.org/C2777956040","wikidata":"https://www.wikidata.org/wiki/Q416554","display_name":"Prostaglandin E2","level":2,"score":0.43589216470718384},{"id":"https://openalex.org/C182704531","wikidata":"https://www.wikidata.org/wiki/Q1364740","display_name":"Knockout mouse","level":3,"score":0.4211495518684387},{"id":"https://openalex.org/C2777198256","wikidata":"https://www.wikidata.org/wiki/Q4860325","display_name":"Prostaglandin E","level":2,"score":0.41818031668663025},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37995249032974243},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.28830721974372864},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25087442994117737},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.12552902102470398}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001643","descriptor_name":"Bridged Bicyclo Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002208","descriptor_name":"Caproates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007414","descriptor_name":"Intestinal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D007414","descriptor_name":"Intestinal Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017353","descriptor_name":"Gene Deletion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017491","descriptor_name":"Genes, APC","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018078","descriptor_name":"Receptors, Prostaglandin E","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058306","descriptor_name":"Receptors, Prostaglandin E, EP1 Subtype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058309","descriptor_name":"Receptors, Prostaglandin E, EP4 Subtype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1349-7006.2003.tb01492.x","doi":"https://doi.org/10.1111/j.1349-7006.2003.tb01492.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1349-7006.2003.tb01492.x","pdf_url":null,"source":{"id":"https://openalex.org/S175946340","display_name":"Cancer Science","issn_l":"1347-9032","issn":["1347-9032","1349-7006"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Science","raw_type":"journal-article"},{"id":"pmid:12841871","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12841871","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer science","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11160211","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11160211/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Sci","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:11160211","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11160211/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Sci","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1500710452","https://openalex.org/W1514189093","https://openalex.org/W1562714701","https://openalex.org/W1648593433","https://openalex.org/W1764097776","https://openalex.org/W2013658096","https://openalex.org/W2026897120","https://openalex.org/W2051686420","https://openalex.org/W2062108645","https://openalex.org/W2067891203","https://openalex.org/W2084615605","https://openalex.org/W2095067529","https://openalex.org/W2113069845","https://openalex.org/W2115522061","https://openalex.org/W2116827973","https://openalex.org/W2121612337","https://openalex.org/W2125471714","https://openalex.org/W2130389194","https://openalex.org/W2154554099","https://openalex.org/W2170717609","https://openalex.org/W2258579859","https://openalex.org/W2308974311","https://openalex.org/W2322783073"],"related_works":["https://openalex.org/W1562714701","https://openalex.org/W2130389194","https://openalex.org/W1980722198","https://openalex.org/W2118972611","https://openalex.org/W2148888228","https://openalex.org/W2415165471","https://openalex.org/W1918606482","https://openalex.org/W2125471013","https://openalex.org/W2563328232","https://openalex.org/W2293158796"],"abstract_inverted_index":{"Previous":[0],"studies":[1],"have":[2,220],"shown":[3],"that":[4,215],"prostaglandin":[5,32],"E(2)":[6],"(PGE(2))":[7],"is":[8],"involved":[9],"in":[10,49,74,77,106,108,120,154,188],"intestinal":[11,47,87],"carcinogenesis":[12],"through":[13],"its":[14],"binding":[15],"to":[16,43,60,79,86,183,225,229],"the":[17,62,81,109,121,125,129,148,155,170,184,189,198,202,209,239],"PGE(2)":[18],"receptor":[19,34,85],"subtypes":[20],"EP(1)":[21,66,210,216],"and":[22,24,30,37,67,142,160,217],"EP(4)":[23,68,199,218],"activation":[25],"of":[26,46,65,83,96,101,117,147,169,186,241],"downstream":[27],"pathways.":[28],"ONO-8711":[29,97,156],"ONO-AE2-227,":[31],"E":[33],"subtype":[35],"EP(1)-":[36],"EP(4)-selective":[38],"antagonists,":[39],"respectively,":[40,164],"are":[41],"known":[42],"suppress":[44],"formation":[45,73,231],"polyps":[48,118,187],"adenomatous":[50],"polyposis":[51],"coli":[52],"gene-deficient":[53],"mice.":[54],"The":[55,114,172],"present":[56],"study":[57],"was":[58,134,178,194,205],"designed":[59],"investigate":[61],"combined":[63],"effects":[64,168],"antagonists":[69],"on":[70],"spontaneous":[71],"polyp":[72,230],"APC1309":[75,89],"mice":[76,90],"order":[78],"determine":[80],"contribution":[82],"each":[84],"tumorigenesis.":[88],"were":[91],"treated":[92],"with":[93,181,197,208],"400":[94,99],"ppm":[95,100],"alone,":[98,157],"ONO-AE2-227":[102,158],"alone":[103,159],"or":[104],"both":[105],"combination":[107,161,234],"diet":[110],"for":[111,176,238],"6":[112],"weeks.":[113],"mean":[115,149],"area":[116],"found":[119],"intestine,":[122],"calculated":[123],"as":[124],"longer":[126],"diameter":[127,131],"x":[128,132],"shorter":[130],"pi,":[133],"reduced":[135],"by":[136],"12%,":[137],"43%":[138],"(P":[139,144],"<":[140,145],"0.01)":[141,146],"56%":[143],"control":[150],"value":[151],"(8.8":[152],"mm(2))":[153],"treatment":[162,235],"groups,":[163],"suggesting":[165],"clear":[166],"additive":[167,174],"combination.":[171],"same":[173],"tendency":[175],"suppression":[177],"also":[179],"observed":[180],"respect":[182],"numbers":[185],"intestine.":[190],"Polyp":[191],"size":[192],"reduction":[193,204],"more":[195,206],"remarkable":[196],"antagonist,":[200],"while":[201],"number":[203],"pronounced":[207],"antagonist.":[211],"Our":[212],"results":[213],"indicate":[214],"may":[219],"separate":[221],"intrinsic":[222],"roles":[223],"and,":[224],"some":[226],"extent,":[227],"contribute":[228],"independently.":[232],"Thus,":[233],"has":[236],"potential":[237],"chemoprevention":[240],"colon":[242],"carcinogenesis.":[243]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}